Roche’s Tecentriq Shows Promise for Progression-Free Survival in Bladder CancerAllbiopro2019-08-06T14:24:52+09:008월 6th, 2019|
Daiichi Sankyo’s Turalio Approved for Rare, Non-Cancerous TumorAllbiopro2019-08-06T14:23:58+09:008월 6th, 2019|
Sosei Heptares and Takeda Ink $1.2 Billion+ Deal to Develop GPCR TargetsAllbiopro2019-08-06T14:23:04+09:008월 6th, 2019|
As Lilly Leans on New Drugs for Growth, Emgality Looks Good for Broader Migraine MarketAllbiopro2019-08-06T14:22:09+09:008월 6th, 2019|
Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINKAllbiopro2019-08-06T14:21:14+09:008월 6th, 2019|
Drugmakers master rolling out their own generics to stifle competitionAllbiopro2019-08-06T14:20:18+09:008월 6th, 2019|
Eli Lilly’s Emgality staves off migraines when other regimens fail: studyAllbiopro2019-08-06T14:19:23+09:008월 6th, 2019|
Daiichi Sankyo wades deeper into oncology with FDA go-ahead in rare joint cancerAllbiopro2019-08-06T14:18:29+09:008월 6th, 2019|
Don’t forget to nominate 2019’s fiercest women in life sciencesAllbiopro2019-08-06T14:17:34+09:008월 6th, 2019|
Lift off! Celgene MS effort launches hot air balloon to highlight brain healthAllbiopro2019-08-06T14:16:39+09:008월 6th, 2019|
Johnson & Johnson scores latest talc trial win as case count reaches 15,500Allbiopro2019-08-06T14:15:45+09:008월 6th, 2019|
Philippine officials consider Sanofi’s Dengvaxia—again—amid deadly outbreakAllbiopro2019-08-06T14:14:50+09:008월 6th, 2019|
Roche’s Tecentriq goes back to its roots with chemo combo win in bladder cancerAllbiopro2019-08-06T14:13:51+09:008월 6th, 2019|
GlycoMimetics shares nearly cut in half as Pfizer-partnered phase 3 drug flopsAllbiopro2019-08-06T14:12:50+09:008월 6th, 2019|
Biocon biosimilar captures 21% of US Neulasta market, eyes capacity boostAllbiopro2019-08-06T14:09:58+09:008월 6th, 2019|
